REVITOPE ONCOLOGY
associated with 8 other trademarks
Development of pharmaceutical preparations for the treatment of cancer; development of platform technology, namely, immunotherapy platforms for manufa...

Words that describe this trademark:

cancer development  development platform  pharmaceutical preparations  treatment cancer  platform technology  preparations  technology  immunotherapy  development  platforms 

Serial Number:

90430409

Mark:

REVITOPE ONCOLOGY

Status:

Registered

Status Date:

01-04-2022

Filing Date:

Registration Number:

6605913

Registration Date:

01-04-2022

Goods and Services:

Development of pharmaceutical preparations for the treatment of cancer; development of platform technology, namely, immunotherapy platforms for manufacturing cancer therapeutics; scientific research services, namely, antibody engineering for analytical and clinical purposes

Mark Description:

N/A

Class:

Scientific and technological services

Type of Mark:

Servicemark

Published for Opposition Date:

10-19-2021

Mark Drawing Status:

Standart Character Mark

Abandon Date:

N/A

Business Name:

STERNE, KESSLER, GOLDSTEIN & FOX, P.L.L.

Correspondent Name:

Recent Trademark filings by this company